Pharsight

Kapspargo Sprinkle patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9504655 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(11 years from now)

US9700530 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(11 years from now)

Kapspargo Sprinkle is owned by Spil.

Kapspargo Sprinkle contains Metoprolol Succinate.

Kapspargo Sprinkle has a total of 2 drug patents out of which 0 drug patents have expired.

Kapspargo Sprinkle was authorised for market use on 26 January, 2018.

Kapspargo Sprinkle is available in capsule, extended release;oral dosage forms.

The generics of Kapspargo Sprinkle are possible to be released after 09 July, 2035.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using METOPROLOL SUCCINATE ingredient

Market Authorisation Date: 26 January, 2018

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

KAPSPARGO SPRINKLE family patents

Family Patents